Selected data models

You must log in to select data models for download or further analysis.

171 Search results.
Relevance Rating New first Old first

Liver and Renal Function After Different Contrast Media NCT01563484 - Eligibility Criteria

- 9/20/21 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media; ODM derived from: https://clinicaltrials.gov/show/NCT01563484

Eligibility Liver Carcinoma NCT01482442

- 6/29/20 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01482442

Eligibility Probiotics before Liver Resection in Liver Disease NCT02021253

- 10/7/20 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Influence of Probiotics Administration Before Liver Resection in Liver Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02021253

Eligibility Liver Cancer NCT02202564

- 3/7/17 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02202564

Eligibility Liver Cancer NCT00614913

- 1/12/16 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Proton Beam Therapy for Treatment of Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00614913

Eligibility Cirrhosis With Hepatocellular Carcinoma NCT01798173

- 12/19/17 - 1 form, 2 itemgroups, 23 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01798173

Appendix 1: Documentation and process of hepatocellular carcinoma for liver transplantation

- 8/24/16 - 1 form, 7 itemgroups, 59 items, 1 language
Itemgroups: Patient information, Diagnosis, Lesion 1, Lesion 2, Lesion 3, Lesion 4, Lesion 5
Appendix 1: Documentation and progress report of hepatocellular carcinoma for liver transplantation Richtlinie gemäß § 16 Abs. 1 S. 1 Nrn. 2 u. 5 TPG für die Wartelistenführung und Organvermittlung zur Lebertransplantation Source: http://www.bundesaerztekammer.de/richtlinien/richtlinien/transplantationsmedizin/richtlinien-fuer-die-wartelistenfuehrung-und-die-organvermittlung/

Eligibility Hepatocellular Carcinoma With Portal Vein Thrombosis NCT01659346

- 2/25/20 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.; ODM derived from: https://clinicaltrials.gov/show/NCT01659346

Eligibility Hepatocellular Carcinoma With Portal Vein Tumor Thrombus NCT01600196

- 9/17/21 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus; ODM derived from: https://clinicaltrials.gov/show/NCT01600196

Eligibility Hepatocellular Carcinoma NCT02149771

- 9/20/21 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Combination Treatment for Advanced Liver Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02149771

Eligibility Neoplasm NCT00988195

- 9/20/21 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Pegylated Human Recombinant Arginase for Liver Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00988195

Eligibility Hepatocellular Carcinoma NCT00848094

- 9/17/21 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Radiation Dose Escalation Study for Advanced Liver Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00848094

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial